An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
Open Access
- 18 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 8
Abstract
Evidence has suggested that the cancer-associated extracellular matrix (ECM) could be recognised as immune-related biomarkers that modulate tumour progression and expansion. However, the ECM-associated immune effect on esophageal squamous cell carcinoma (ESCC) prognosis and therapy has not been well characterised. In our study, we first constructed an ECM-related signature including four genes CST1, NELL2, ADAMTSL4, and ANGPTL7 by multivariate Cox regression analyses. This signature could serve as a marker to evaluate the prognosis of patients with ESCC and was successfully validated in testing and combined (training plus testing) cohorts. We also found that there were significant different therapeutic responses to chemotherapy and targeted drugs between the high-risk and low-risk groups of patients defined by the signature. Furthermore, the expression of four genes and immune function analysis suggested that this ECM-related signature gene might play important roles in the changes of the tumour microenvironment. In conclusion, our findings demonstrated that the ECM-related signature might serve as an independent prognostic factor and provide a potential biomarker for chemotherapy responses for patients with ESCC.Keywords
Funding Information
- National Natural Science Foundation of China (81773116, 81760436, 81560399, 81460362, 81860518)
This publication has 53 references indexed in Scilit:
- ADAMTS proteins as modulators of microfibril formation and functionMatrix Biology, 2015
- Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinomaCancer Science, 2015
- The extracellular matrix modulates the hallmarks of cancerEMBO Reports, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motilityJournal of Clinical Investigation, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Extracellular Matrix: Not Just Pretty FibrilsScience, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009